is on the advisory board and does consultancy and lectures for NovoNordisk, AstraZeneca, Sanofi, Boehringer, Lilly, Mundipharma and Sankyo
Key Takeaways for Patients Considering GLP-1 at Home I recommend understanding that BMI is a guideline, but your overall health determines eligibility
Interim pharmacokinetic and safety updates continue to support the Phase 2 profile, and researchers are closely watching for the larger, longer-duration data that will ultimately shape the regulatory trajectory for the molecule
Most people begin noticing appetite suppression within 1 to 2 weeks, measurable weight loss within 2 to 4 weeks, and more significant results within 8 to 12 weeks
The MHRA has dismantled UK-based illicit manufacturing operations producing fake retatrutide and tirzepatide pens, and counterfeit products have been found to contain the wrong dose, the wrong drug, or contaminants
While similar, they differ in how they work and how theyre dosed